Neon Therapeutics, Inc. Made Headway
Thu, Jan 16, 2020 at 05:30 PM
Neon Therapeutics, Inc. (NTGN:NASDAQ) jumped higher at $1.7, representing a gain of 38.2%. On Wed 15 Jan 20, NTGN:NASDAQ hit a New 2-Week Intraday High of $1.29. The stock appeared on our News Catalysts scanner on Thu 16 Jan 20 at 08:29 AM in the 'ACQUISITION' category. From Tue 24 Dec 19, the stock recorded 42.86% Up Days and 26.67% Green Days
The share price of the company has been moving sideways in recent weeks.
About Neon Therapeutics, Inc. (NTGN:NASDAQ)
Neon Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused in the field of neoantigen-targeted therapies, dedicated to transforming the treatment of cancer by directing the immune system towards neoantigens. The company's pipeline products are NEO-PV-01, NEO-PTC-01, and NEO-SV-01.
Top 10 Gainers:
- The McClatchy Company (MNI:NASDAQ), 241.84%
- Aethlon Medical, Inc. (AEMD:NASDAQ), 57.71%
- TRACON Pharmaceuticals, Inc. (TCON:NASDAQ), 46.76%
- Internap Corporation (INAP:NASDAQ), 40.86%
- PolarityTE, Inc. (PTE:NASDAQ), 40.51%
- Signet Jewelers Limited (SIG:NYSE), 40.2%
- NantKwest, Inc. (NK:NASDAQ), 39.25%
- Neon Therapeutics, Inc. (NTGN:NASDAQ), 38.21%
- Cemtrex, Inc. (CETX:NASDAQ), 37.91%
- Proteon Therapeutics, Inc. (PRTO:NASDAQ), 30.5%